Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization

Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization

US Patent 6696480 · Granted Feb 24, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-inflammatory actions of cytochrome P450 expoxygenase-derived eicosanoids2005
Increasing cerebral bioavailability of drugs2004
Methods of identifying a compound which modulates the non-transcriptional non-ma2003
Liquid crystal display2003
Liquid crystal display2003
Upregulation of type III endothelial cell nitric oxide synthase by agents that d2002
Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase fu2001
Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reduc2000